A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis
Clinical trial NCT05250973 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05250973
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2026-02-04
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.